Fuh-Ngwa V - Search Results

1

A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis.

Stevens N, Ezegbe C, Fuh-Ngwa V, Makowiecki K, Zarghami A, Nguyen PT, Sansom J, Smith K, Laslett LL, Denham M, Cullen CL, Barnett MH, Hinder MR, Breslin M, Young KM, Taylor BV. Stevens N, et al. Among authors: fuh ngwa v. Trials. 2024 Sep 8;25(1):598. doi: 10.1186/s13063-024-08425-x. Trials. 2024. PMID: 39245707 Free PMC article.

2

Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study.

Zarghami A, Fuh-Ngwa V, Claflin SB, van der Mei I, Ponsonby AL, Broadley S, Simpson-Yap S; Ausimmune/AusLong Investigator Group; Taylor BV. Zarghami A, et al. Among authors: fuh ngwa v. Eur J Neurol. 2024 Jan;31(1):e16016. doi: 10.1111/ene.16016. Epub 2023 Aug 13. Eur J Neurol. 2024. PMID: 37525323 Free PMC article.

3

The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-centre, longitudinal cohort study.

Fuh-Ngwa V, Charlesworth JC, Zhou Y, van der Mei I, Melton PE, Broadley SA, Ponsonby AL, Simpson-Yap S, Lechner-Scott J, Taylor BV. Fuh-Ngwa V, et al. Sci Rep. 2023 Jul 18;13(1):11584. doi: 10.1038/s41598-023-38415-z. Sci Rep. 2023. PMID: 37463930 Free PMC article.

4

Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression.

Lin X, Yang Y, Fuh-Ngwa V, Yin X, Simpson-Yap S, van der Mei I, Broadley SA, Ponsonby AL; Ausimmune/ AusLong Investigators Group; Burdon KP, Taylor BV, Zhou Y. Lin X, et al. Among authors: fuh ngwa v. J Neurol Neurosurg Psychiatry. 2023 Jul;94(7):526-531. doi: 10.1136/jnnp-2022-330259. Epub 2023 Feb 2. J Neurol Neurosurg Psychiatry. 2023. PMID: 36732044

5

Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis.

Fuh-Ngwa V, Zhou Y, Melton PE, van der Mei I, Charlesworth JC, Lin X, Zarghami A, Broadley SA, Ponsonby AL, Simpson-Yap S, Lechner-Scott J, Taylor BV. Fuh-Ngwa V, et al. Sci Rep. 2022 Nov 11;12(1):19291. doi: 10.1038/s41598-022-23685-w. Sci Rep. 2022. PMID: 36369345 Free PMC article.

6

Novel plasma and brain proteins that are implicated in multiple sclerosis.

Lin X, Yang Y, Gresle M, Cuellar-Partida G, Han X, Stankovich J; AusLong/Ausimmune Investigators Group; Simpson-Yap S, Fuh-Ngwa V, Charlesworth J, Burdon KP, Butzkueven H, Taylor BV, Zhou Y. Lin X, et al. Among authors: fuh ngwa v. Brain. 2023 Jun 1;146(6):2464-2475. doi: 10.1093/brain/awac420. Brain. 2023. PMID: 36346149

7

Developing a clinical-environmental-genotypic prognostic index for relapsing-onset multiple sclerosis and clinically isolated syndrome.

Fuh-Ngwa V, Zhou Y, Charlesworth JC, Ponsonby AL, Simpson-Yap S, Lechner-Scott J, Taylor BV; AusLong/Ausimmune Investigators Group. Fuh-Ngwa V, et al. Brain Commun. 2021 Dec 4;3(4):fcab288. doi: 10.1093/braincomms/fcab288. eCollection 2021. Brain Commun. 2021. PMID: 34950873 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters